Vimarsana
Biggest News Aggregation in the World

Page 10 - Breakthrough Device News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Device Today - Breaking & Trending Today

CMS Assigns Accretive Reimbursement for RefleXion's Breakthrough SCINTIX Therapy - Vimarsana News

CMS Assigns Accretive Reimbursement for RefleXion's Breakthrough SCINTIX Therapy

New codes and payment expected to facilitate clinical adoption of novel cancer treatment option

3Spine Announces Completion of FDA Clinical Trial Enrollment Achieving 325 Surgeries in 2023 - Vimarsana News

3Spine Announces Completion of FDA Clinical Trial Enrollment Achieving 325 Surgeries in 2023

3Spine, Inc., a medical device company developing a transformational alternative to lumbar spinal fusion, today announced achievement of US clinical trial enrol

3Spine Announces Completion of FDA Clinical Trial Enrollment Achieving 325 Surgeries in 2023 - Vimarsana News

3Spine Announces Completion of FDA Clinical Trial Enrollment Achieving 325 Surgeries in 2023

3Spine, Inc., a medical device company developing a transformational alternative to lumbar spinal fusion, today announced achievement of US clinical trial enrol

Will There Be a Little Blue Pill for Postmenopausal Women? - Vimarsana News

Will There Be a Little Blue Pill for Postmenopausal Women?

Postmenopausal women have a dizzying array of pills, inserts and devices to amp up their sex lives these days, as money finally flows for women's sexual health solutions. But is sex actually getting any better? Are we anywhere closer to a Viagara-like game-changer that will usher in a new frontier of female pleasure for older women?  

Prescription Digital Therapeutic for Schizophrenia Receives FDA Breakthrough Device Designation - Vimarsana News

Prescription Digital Therapeutic for Schizophrenia Receives FDA Breakthrough Device Designation

The device is currently under clinical trial investigation as an adjunct treatment to standard of care therapy for experiential negative symptoms of schizophrenia.